Greg M Allen

8PUBLICATIONS
79CO-AUTHORS
Molecular targetsPhotovoltaic power systemsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular, biological, and multi-scale communications
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 15, 2026
Disruption of the CRL5 ubiquitin ligase complex enhances engineered T-cell persistence under chronic tumor antigen exposure.

|Oct 07, 2026
Programmable CAR-engaging particles rewire human CAR T-cell signaling for sustainable ex vivo expansion.

|Aug 12, 2026
In vivo genome-wide CRISPR screens of human T cells in solid tumours.

|Dec 05, 2024
Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programs.

Nishith R Reddy, Hasna Maachi, Yini Xiao

|Jul 19, 2024
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.

Collin M Blakely, Anatoly Urisman, Matthew A Gubens

|Dec 15, 2022
Synthetic cytokine circuits that drive T cells into immune-excluded tumors.

Greg M Allen, Nicholas W Frankel, Nishith R Reddy

Pageof 2

Frequent Collaborators

5 joint publications

Wendell A Lim

3 joint publications

Justin Eyquem

2 joint publications

Jasper Z Williams

2 joint publications

Julia Carnevale